Actimed Therapeutics Licenses Additional European Patent Rights to S-oxprenolol in ALS from Charité - Universitätsmedizin Berlin

The licensing of this intellectual property covers patent rights in all major European markets including Germany, France, UK, Italy and Spain for the treatment of ALS.